Announce Date | 07/31/2025 |
EPS Normalized Actual | $0.51 (Miss by $-0.01) |
EPS GAAP Actual | $0.51 (Miss by $-0.01) |
Revenue Actual | $2.5175B |
Revenue Surprise | Beat by $2517.5M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.43639 |
EPS GAAP Estimate | $0.43639 |
Revenue Estimate | $2.515446667B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.85 | 6.56 | 3.77282 | 3.94388 | 1 |
Dec 2028 | 3.49 | 7.23 | 3.42878 | 3.53073 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.07 | -0.38977 | 2.5175B | 5.76% | -17.66M |
FQ1 2025 (Mar 2025) | -0.09 | -0.09 | 2.12755B | -2.99% | 2127.55M |
FQ4 2024 (Dec 2024) | 0.58 | 0.58 | 2.10937B | 5.83% | 2109.37M |
FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 2.80658B | 9.64% | 2806.58M |
FQ2 2024 (Jun 2024) | 0.38 | 0.38 | 2.37249B | 27.96% | 2372.49M |
FQ1 2024 (Mar 2024) | 0.0407 | 0.0407 | 2.19122B | 16.85% | 2191.22M |
FQ4 2023 (Dec 2023) | -0.25 | -0.25 | 1.98646B | 23.53% | 1986.46M |
FQ3 2023 (Sep 2023) | 0.81 | 0.81 | 2.53604B | 36.3% | 2536.04M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.43639
Consensus Revenue Estimates
2.515446667B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.46 | -- | 0.44836 | 0.4735 | 6 |
FQ3 2027 (Sep 2027) | 1.64 | -- | 1.61189 | 1.66295 | 3 |
FQ2 2027 (Jun 2027) | 0.81 | -- | 0.79612 | 0.82134 | 5 |
FQ1 2027 (Mar 2027) | 0.33 | -- | 0.32434 | 0.33462 | 3 |
FQ4 2026 (Oct 2026) | 1.19081 | -- | 1.11438 | 1.23512 | 7 |
FQ3 2026 (Jul 2026) | 0.54593 | -- | 0.51089 | 0.56624 | 4 |
FQ2 2026 (Jun 2026) | 0.64776 | 89.19 | 0.59962 | 0.68463 | 4 |
FQ1 2026 (Mar 2026) | 0.22973 | 139.18 | 0.21266 | 0.24281 | 4 |
FQ4 2025 (Oct 2025) | 0.99475 | 41.69 | 0.9309 | 1.03177 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.7B | -- | 2.65B | 2.76B | 14 |
FQ3 2027 (Sep 2027) | 3.65B | -- | 3.61B | 3.69B | 3 |
FQ2 2027 (Jun 2027) | 3.09B | -- | 3.05B | 3.13B | 3 |
FQ1 2027 (Mar 2027) | 2.65B | -- | 2.61B | 2.67B | 3 |
FQ4 2026 (Oct 2026) | 3.25B | -- | 3.09B | 3.34B | 5 |
FQ3 2026 (Jul 2026) | 2.75B | -- | 2.62B | 2.83B | 5 |
FQ2 2026 (Jun 2026) | 2.79B | 9.83 | 2.63B | 2.91B | 4 |
FQ1 2026 (Mar 2026) | 2.47B | 13.97 | 2.33B | 2.58B | 7 |
FQ4 2025 (Oct 2025) | 2.92B | 27.7 | 2.77B | 3B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.45977 | 0.07 | -0.38977 | -556.81% |
FQ1 2025 (Mar 2025) | -0.09 | -0.09 | 100% | |
FQ4 2024 (Dec 2024) | 0.58 | 0.58 | 100% | |
FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 100% | |
FQ2 2024 (Jun 2024) | 0.38 | 0.38 | 100% | |
FQ1 2024 (Mar 2024) | 0.0407 | 0.0407 | 100% | |
FQ4 2023 (Dec 2023) | -0.25 | -0.25 | 100% | |
FQ3 2023 (Sep 2023) | 0.81 | 0.81 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.54B | $2.52B | $-17.66M | -0.7% |
FQ1 2025 (Mar 2025) | $0B | $2.13B | $2127.55M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.11B | $2109.37M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.81B | $2806.58M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.37B | $2372.49M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.19B | $2191.22M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.99B | $1986.46M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.54B | $2536.04M | 100% |